Landos Biopharma Inc.
LABP
|
|
| |
|
| Trading Volume | 193,831 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | -40.4% | -69.3% |
| Q2 | - | - | 4% | -50.6% |
| Q3 | - | - | - | -10.7% |
| Q4 | - | - | - | -23.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -14 | -14 | -19.5 | -6 | 10.7 | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -30.2 | -36.4 | -30.8 | -35.3 | -24 | 0.3 | 12.9 | 9.5 | -27.8 | -48 | -36.4 | 132.6 |
| 2021 | |||||||||||
| - | - | -26.5 | 18 | -3.4 | 5.2 | -4.9 | 21 | 9.9 | -7.8 | -48.6 | -30.6 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.9 | -0.4 | -0.4 |
| Q2 | -0.6 | -0.3 | 0.1 |
| Q3 | -0.9 | -0.2 | -0.3 |
| Q4 | 0 | -1.3 | -0.4 |
| A | -2.47 | -1 | -1 |